Key result
Picroside II protects cardiomyocytes against hypoxia/reoxygenation injury by reducing oxidative stress and calcium overload.
Why the study?
The protective effect of picroside II against hypoxia/reoxygenation-induced cardiomyocyte injury is poorly understood.
Picroside II demonstrates cardioprotective effects against hypoxia/reoxygenation injury in neonatal rat cardiomyocytes by reducing oxidative stress and calcium accumulation.
CONTEXT: Picroside II, an iridoid glucoside found in the root of Picrorhiza scrophulariiflora Pennell (Scrophulariaceae), has been demonstrated to possess potent antioxidant activity. However, whether picroside II has a protective effect against hypoxia/reoxygenation (H/R)-induced cardiomyocyte injury is poorly understood. OBJECTIVE: To explore the cardioprotective role of picroside II against oxidative stress induced by H/R injury in neonatal rat cardiacmyocytes. MATERIALS AND METHODS: The viability and cellular damage of cardiomyocytes were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolim bromide (MTT) and lactate dehydrogenase (LDH) assays, respectively. The activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), the levels of reduced (GSH) and oxidized glutathione (GSSG), and the contents of malondialdehyde (MDA) were determined by a colorimetric method. The levels of intracellular reactive oxygen species (ROS) and calcium were evaluated by flow cytometric analysis. RESULTS: We analyzed the effective half-maximal concentration for protection from the dose-response curves and obtained the concentration of 50 µg/mL as EC(50). Pretreated cardiomyocytes with picroside II (50-200 µg/mL), prior to H/R exposure, inhibited LDH activity in culture media and increased cell viability in a dose-dependent manner. This protective effect was accompanied by significantly increasing reduced GSH contents and the activities of SOD and GSH-Px and attenuating MDA and GSSG contents in response to H/R injury. Furthermore, treatment with picroside II also inhibited ROS production and calcium accumulation in cardiomyocytes. DISCUSSION AND CONCLUSION: The present study demonstrates that picroside II protects cardiomyocytes against oxidative-stress injury induced by H/R through reduction of ROS production and calcium accumulation and enhancement of the activity of antioxidant defense.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2012) studied Hypoxia/reoxygenation (H/R)-induced cardiomyocyte injury. Picroside II vs. Hypoxia/reoxygenation exposure without picroside II was evaluated on Cell viability and cellular damage (LDH activity, ROS production, calcium accumulation). Pretreatment of neonatal rat cardiomyocytes with picroside II (50-200 µg/mL) protected against hypoxia/reoxygenation injury by reducing ROS production and calcium accumulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: